Inventor · disambiguated record
Kazuhiro Ito
Also filed as: ITO KAZUHIRO
52 granted patents·10 pending applications·640 citations·filing 1993–2023
98Inventor score
Top patents by PatentIndex Score
62 records- 0197US9108950B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2012·Granted Aug 18, 2015·38 cites·13 claims
- 0296US10858345B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2020·Granted Dec 8, 2020·3 cites·20 claims
- 0396US8642773B2P38MAP kinase inhibitorITO KAZUHIRO·Filed 2010·Granted Feb 4, 2014·44 cites·4 claims
- 0496US8293771B2p38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 23, 2012·49 cites·9 claims
- 0596US8293748B2p38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 23, 2012·47 cites·19 claims
- 0695US9732098B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativeHUNT SIMON FRASER·Filed 2015·Granted Aug 15, 2017·32 cites·13 claims
- 0795US8618140B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2012·Granted Dec 31, 2013·41 cites·20 claims
- 0895US8299073B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 30, 2012·50 cites·19 claims
- 0995US8299074B2P38 MAP kinase inhibitorsITO KAZUHIRO·Filed 2009·Granted Oct 30, 2012·48 cites·17 claims
- 1094US11008307B2Compounds which are used in the preparation of the compound of formula (I)PULMOCIDE LTD·Filed 2020·Granted May 18, 2021·2 cites·5 claims
- 1194US10106531B2Compound useful to treat mycosesPULMOCIDE LTD·Filed 2015·Granted Oct 23, 2018·10 cites·34 claims
- 1294US8975285B2P38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Mar 10, 2015·26 cites·3 claims
- 1393US11661415B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2020·Granted May 30, 2023·2 cites·20 claims
- 1493US10662179B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2019·Granted May 26, 2020·3 cites·20 claims
- 1593US10487073B2Compounds which are used in the preparation of the compound of formula (I)PULMOCIDE LTD·Filed 2018·Granted Nov 26, 2019·7 cites·3 claims
- 1693US10344022B2Compound useful to treat mycosesPULMOCIDE LTD·Filed 2018·Granted Jul 9, 2019·7 cites·19 claims
- 1792US10738032B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2019·Granted Aug 11, 2020·3 cites·24 claims
- 1892US9475796B21-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2012·Granted Oct 25, 2016·12 cites·14 claims
- 1992US9249125B2Pyrazole derivatives as p38 MAP inhibitorsRESPIVERT LTD·Filed 2013·Granted Feb 2, 2016·30 cites·12 claims
- 2091US10800762B2Compounds which are used in the preparation of the compound of formula (II)PULMOCIDE LTD·Filed 2019·Granted Oct 13, 2020·2 cites·2 claims
- 2191US10266519B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Apr 23, 2019·6 cites·11 claims
- 2291US5374627AMethods for protecting vegetables, turfgrass, rice and fruit trees from fungi and bacteriaNAKANO VINEGAR CO LTD·Filed 1993·Granted Dec 20, 1994·66 cites·18 claims
- 2390US10450304B2Compound useful to treat mycosesPULMOCIDE LTD·Filed 2019·Granted Oct 22, 2019·4 cites·10 claims
- 2489US10093659B2Compound useful to treat mycosesSUNOSE MIHIRO·Filed 2016·Granted Oct 9, 2018·7 cites·15 claims
- 2589US9724347B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitorsRESPIVERT LTD·Filed 2016·Granted Aug 8, 2017·5 cites·17 claims
- 2688US9850231B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Dec 26, 2017·5 cites·8 claims
- 2787US12269814B2Process for preparing a compound useful to treat mycosesPULMOCIDE LTD·Filed 2023·Granted Apr 8, 2025·0 cites·20 claims
- 2886US10238658B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitorsRESPIVERT LTD·Filed 2018·Granted Mar 26, 2019·3 cites·19 claims
- 2985US9242960B2P38MAP kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Jan 26, 2016·6 cites·6 claims
- 3085US9079893B2Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (RSV) infectionCASS LINDSEY·Filed 2011·Granted Jul 14, 2015·21 cites·1 claims
- 3185US8741909B2PI3 kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2010·Granted Jun 3, 2014·7 cites·25 claims
- 3284US9260410B2P38 MAP kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2011·Granted Feb 16, 2016·7 cites·10 claims
- 3383US10189863B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativesPULMOCIDE LTD·Filed 2015·Granted Jan 29, 2019·3 cites·24 claims
- 3483US9993478B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitorsRESPIVERT LTD·Filed 2017·Granted Jun 12, 2018·2 cites·19 claims
- 3583US9701670B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Jul 11, 2017·10 cites·18 claims
- 3682US10035810B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2018·Granted Jul 31, 2018·2 cites·7 claims
- 3781US9926335B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativeHUNT SIMON FRASER·Filed 2017·Granted Mar 27, 2018·2 cites·4 claims
- 3880US2024343711A11-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- i - yl) ureas as p38 mapkinase inhibitorsRESPIVERT LTD·Filed 2023·Application pending·0 cites
- 3978US9321773B2CompoundsRESPIVERT LTD·Filed 2014·Granted Apr 26, 2016·2 cites·1 claims
- 4077US2021238169A1Process for preparing a compound of formula (xiii)PULMOCIDE LTD·Filed 2021·Application pending·0 cites
- 4174US9834560B2CompoundsRESPIVERT LTD·Filed 2016·Granted Dec 5, 2017·1 cites·21 claims
- 4273US9969720B2Compounds useful to treat mycosesCOLLEY THOMAS CHRISTOPHER·Filed 2016·Granted May 15, 2018·2 cites·19 claims
- 4373US9340545B2Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted May 17, 2016·1 cites·8 claims
- 4472US6448247B1Method for treating an inflammatory diseaseSANKYO CO·Filed 2000·Granted Sep 10, 2002·6 cites·51 claims
- 4569US10813932B21-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitorsRESPIVERT LTD·Filed 2019·Granted Oct 27, 2020·0 cites·18 claims
- 4668US10472375B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2019·Granted Nov 12, 2019·0 cites·6 claims
- 4768US10273249B25,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivativePULMOCIDE LTD·Filed 2018·Granted Apr 30, 2019·0 cites·5 claims
- 4863US10513511B2Aqueous suspension formulation comprising 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl) or a pharmaceutically acceptable salt thereofPULMOCIDE LTD·Filed 2019·Granted Dec 24, 2019·0 cites·16 claims
- 4961US2018000830A1Inhibitors of hemopoietic cell kinase (p-59-hck) and their use in the treatment of influenza infectionRESPIVERT LTD·Filed 2017·Application pending·0 cites
- 5060US10280155B2Process for preparing 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-N-((1S,2S)-2-hydroxycyclohexyl) benzamide or a pharmaceutically acceptable salt thereofPULMOCIDE LTD·Filed 2018·Granted May 7, 2019·0 cites·3 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kazuhiro Ito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →